How We Research

How We Research

Transparency in Health Literacy

At Aging Health Research, we believe that health literacy is the foundation of patient advocacy. In an era of AI-generated misinformation and “Hollywood medical myths,” our mission is to provide seniors and caregivers with data that is verified, current, and actionable.

Every article published on this platform undergoes a rigorous 4-step verification process before it reaches your screen.

1. The Hierarchy of Evidence (Sourcing)

We do not rely on social media trends or anecdotal “miracle cures.” We prioritize sources in the following order:

  • Tier 1: Clinical Practice Guidelines (e.g., AASLD, NIA, American Heart Association).
  • Tier 2: Peer-Reviewed Meta-Analyses (Studies that synthesize data from dozens of individual trials).
  • Tier 3: Institutional Data (CDC, National Institutes of Health, World Health Organization).
  • Tier 4: Expert Consensus (Standardized protocols used by leading geriatric teaching hospitals).

2. The “Full Rule-Out” Methodology

We advocate for a comprehensive diagnostic approach. When researching cognitive or metabolic issues, we look for the Metabolic Mimics.

  • Example: Before identifying “Early Dementia,” we research and highlight the need to rule out Vitamin B12 deficiency, thyroid dysfunction, and ammonia buildup (Hepatic Encephalopathy).
  • Our goal is to help you move from a “state of fear” to a “state of data.”

3. Standardized 2026 Clinical Targets

To ensure consistency across our 330+ articles, we use a set of Universal Clinical Benchmarks updated for March 2026:

  • Blood Pressure: Target <130/80 mmHg for neuro-vascular protection.
  • Protein Intake: 1.2–1.6 g/kg of high-quality protein to combat Sarcopenia.
  • Metabolic Integrity: Focus on nutrient-dense, full-fat dairy and low-glycemic carbohydrates.

4. Author Identity & Experience

Research is driven by experience. Our founder, Tommy T. Douglas, is an independent researcher who has navigated:

  • Survival and recovery from a major heart attack (2008).
  • Management of Type 2 Diabetes (Metformin & GLP-1 therapy).
  • Management of Decompensated Cirrhosis and Portal Hypertension.

🧬 Precision Medicine & Genetics Glossary

To support our research into Colon Cancer and other genomic conditions, we use the following clinical definitions:

  • Lynch Syndrome: An inherited condition that increases the risk of colon and other cancers due to mutations in DNA repair genes (MLH1, MSH2, MSH6, PMS2).
  • PIK3CA Mutation: A biomarker that helps determine if low-dose aspirin will effectively reduce recurrence in certain colon cancer patients.
  • ctDNA (Liquid Biopsy): “Circulating Tumor DNA”—a highly sensitive blood test that can detect cancer recurrence months before a traditional scan.
  • BRAF V600E: A specific genetic mutation that can be targeted with specific 2026-approved drug combinations.

Medical Disclaimer

Aging Health Research provides educational information and is not a substitute for professional medical advice. Always consult your healthcare partner before making changes to your medication or lifestyle protocols.